Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine.

Anesthesiology - 1 Mar 2005

Levano Soledad, Ginz Hans, Siegemund Martin, Filipovic Miodrag, Voronkov Evgueni, Urwyler Albert, Girard Thierry

Abstract excerpt

BACKGROUND: Succinylcholine remains the standard neuromuscular blocking drug for tracheal intubation in emergency situations. The short duration of action is due to its rapid hydrolytic degradation by butyrylcholinesterase (plasmacholinesterase). Multiple variants of this enzyme are known (A, F, S, H, J, K variants) with different effects on enzyme activity. This study was undertaken to evaluate the use of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Butyrylcholinesterase

Share to Genotype

Share to Mutation

Share to Succinylcholine

Share to Time Factors

Source

Identifiers

PMID: 15731589
DOI: 10.1097/00000542-200503000-00009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genotyping the butyrylcholinesterase in patients with prolonged neuromuscular block after succinylcholine.PMID 15731589Read ↗

Patients with prolonged effect of succinylcholine or mivacurium had novel mutations in the butyrylcholinesterase gene.Semantic proximity Read ↗

Two novel mutations in the BCHE gene in patients with prolonged duration of action of mivacurium or succinylcholine during anaesthesia.Semantic proximity Read ↗

Predictors of the variability in neuromuscular block duration following succinylcholine: A prospective, observational study.Semantic proximity Read ↗

Response to succinylcholine in patients carrying the K-variant of the butyrylcholinesterase gene.Semantic proximity Read ↗

Screening patients with prolonged neuromuscular blockade after succinylcholine and mivacurium.Semantic proximity Read ↗

Butyrylcholinesterase gene mutations in patients with prolonged apnea after succinylcholine for electroconvulsive therapy.Semantic proximity Read ↗

Phenotype and genotype characteristics of 58 patients showing a prolonged effect of succinylcholine: A four-year experience.Semantic proximity Read ↗

Rapid and accurate detection of atypical and Kalow variants in the butyrylcholinesterase gene using denaturing high performance liquid chromatography.Semantic proximity Read ↗

Rapid identification of atypical variant of plasma butyrylcholinesterase by PCR.Semantic proximity Read ↗

Genotype-phenotype relationships in butyrylcholinesterase deficiency: a systematic review.Semantic proximity Read ↗

Plasma cholinesterase and abnormal reaction to succinylcholine: twenty years' experience with the Danish Cholinesterase Research Unit.Semantic proximity Read ↗

Analysis of mutations in the plasma cholinesterase gene of patients with a history of prolonged neuromuscular block during anesthesia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.